T-cell tweaks to target tumours

Marcela V. Maus ()
Additional contact information
Marcela V. Maus: Harvard Medical School, and the Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.

Nature, 2017, vol. 543, issue 7643, 48-49

Abstract: Immune cells known as T cells can destroy tumour cells, but their clinical use requires complex preparation and the cells can lose effectiveness over time. A new approach might improve the efficiency of T-cell therapy. See Letter p.113

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature21506 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:543:y:2017:i:7643:d:10.1038_nature21506

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature21506

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().